Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.euroneuro.2024.10.010 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Lurasidone-related adverse events: A comprehensive analysis from the FAERs database in real-world settings.
Eur Neuropsychopharmacol
January 2025
Affiliated Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu 214151, China. Electronic address:
Possible Lurasidone-Associated Dose-Dependent QTc Prolongation in First-Episode Psychosis.
Psychopharmacol Bull
June 2022
Naguy, MBBch, MSc, Child/Adolescent Psychiatrist, Al-Manara CAP Centre, Kuwait Centre for Mental Health (KCMH), Jamal Abdul-Nassir St, Shuwaikh, State of Kuwait. Prof. Suliman Al-Khadhari, FRCP(Canada), Consultant Psychiatrist, Professor and Head of Psychiatry Department, Faculty of Medicine, Kuwait University, State of Kuwait. Prof. Saxby Pridmore, MD, Professor of Psychiatry, University of Tasmania, Hobart, Australia.
This case is one of the earliest to report on lurasidone-related QTc prolongation in a dose-dependent fashion in CAP population at therapeutic doses. Although these reports remain scarce, it behoves prescribers to be vigilant and mindful of these unusual but serious side effects especially in setting of cumulative risks.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!